Publication of a Supplement

Source: RNS
RNS Number : 7597O
British Telecommunications PLC
02 February 2023

2 February 2023

British Telecommunications public limited company

Publication of Supplement updating the Euro Medium Term Note Programme

The following Supplement has been approved by the Financial Conduct Authority and is available for viewing:

Supplement dated 2 February 2023 (the "Supplement") relating to the €20,000,000,000 Euro Medium Term Note Programme of British Telecommunications public limited company.

The Supplement incorporates by reference BT Group plc's Trading Update for the nine months to 31 December 2022.

To view the Supplement in full, please click on the link below:

A copy of the Supplement will be submitted to the National Storage Mechanism and will be available shortly for inspection at:

For further information, please contact:

BT Group Investor Relations

Tel: 0800 389 4909





Please note that the information contained in the Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus dated 17 June 2022) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Supplement is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained in the Supplement.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.